Situation · 2026-06-12

REGN — Profile and price weak

Discounted for Margin Pressure, Not Growth Failure

Updated 2026-05-28 · Ref: Healthcare

Key metrics — 2026-05-28

Peer score

Quality pct

Valuation pct

52w drawdown

-23.3%

21d vs sector

-15.9%

Peer group

Healthcare

Situation summary

Regeneron trades at a discount for margin volatility and operational setbacks. Gross margin has slipped to 77%, and pipeline risks weigh on confidence. The market wants proof of margin stability. Cheap for a reason.

Published by AssetNext · 2026-05-19

All companies with this signal today

View full list: Profile and price weak →

Related pages for REGN

Full peer analysis for Regeneron Pharmaceuticals, Inc. →Similar companies to REGN REGN peers All REGN comparisons Nasdaq-100 context

Signal history — last 30 days

Date	Signal	Peer score	Drawdown	21d vs sector
2026-05-28	Profile and price weak	61	-23.3%	-15.9%
2026-05-18	Profile and price weak	61	-22.4%	-21.6%
2026-05-18	Profile and price weak	60	-22.4%	-10.8%

See REGN's full peer analysis

Break down REGN's structural position across all peer dimensions with the interactive app.

Open REGN in AssetNext →